Countries will discuss drug safety
The World Health Organization (WHO) promotes the 35th International Drug Monitoring Programme annual meeting in Brasília, Brazil. The program’s objective is to strengthen pharmacovigilance actions in the world and to ensure the marketing of safe and effective drugs. The event will be supported by the Brazilian Health Surveillance Agency – Anvisa, and will be opened next Monday, 12 November, at 9am at Brasil 21 Event Center.